Multivessel Disease As A Prognostic Marker In Patients Presenting For Primary Percutaneous Coronary Intervention

Mahesh Kumar Batra1, Syed Ishtiaq Rasool1, Bashir Ahmed Solangi1

  • 1Cardiology Department, National Institute of Cardiovascular Diseases, Karachi, Pakistan.

Insights

Multi-vessel disease in ST-Elevation Myocardial Infarction (STEMI) patients undergoing primary PCI leads to worse outcomes, including higher mortality and complications. This highlights the critical impact of multi-vessel disease on patient prognosis and hospital stay.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Multi-vessel disease (MVD) is linked to increased mortality in ST-Elevation Myocardial Infarction (STEMI) patients.
  • MVD can significantly influence clinical course and treatment decisions in STEMI.
  • Primary Percutaneous Coronary Intervention (PCI) is a key treatment for STEMI.

Purpose of the Study:

  • To determine the prevalence of MVD in STEMI patients undergoing primary PCI.
  • To compare in-hospital and early post-discharge outcomes (up to 30 days) between STEMI patients with MVD and single-vessel disease (SVD).

Main Methods:

  • A study of 282 consecutive STEMI patients undergoing primary PCI at NICVD, Karachi.
  • Assessment and comparison of demographic data, clinical history, procedural complications, and short-term adverse events between SVD and MVD groups.
  • Statistical analysis using z-test, t-test, and Fisher's Exact test.

Main Results:

  • Patients with MVD experienced worse post-procedural outcomes compared to SVD patients.
  • MVD was associated with increased overall complications, longer hospital stays, and higher in-hospital mortality.
  • Higher referral rates for Coronary Artery Bypass Grafting (CABG) were observed in the MVD group.
  • A trend towards higher symptom recurrence and re-admission was noted in MVD patients, though not statistically significant.

Conclusions:

  • MVD in STEMI patients undergoing primary PCI is a direct indicator of significantly higher post-procedure complications, mortality, and morbidity.
  • Prolonged hospitalization is a key consequence of MVD in this patient population.
  • The risk of symptom recurrence and re-admission remains elevated for STEMI patients with MVD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Nursing Interventions I: Taxonomy of Nursing Interventions01:03

Nursing Interventions I: Taxonomy of Nursing Interventions

Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
3.8K